Desq Long
Sign in

Company

AGIOS PHARMACEUTICALS, INC.

AGIO · CIK 0001439222

SEC FORM 4
$12,505.00

AGIOS PHARMACEUTICALS, INC. (AGIO)

Acquisition (code M) of 500 shares at $25.01 per share.

Reporting Person Gheuens Sarah · Officer Title Chief Medical Officer · Transaction Code M

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001439222-26-000122 · filed 2026-10-23 · View filing →

SEC FORM 4
$18,760.00

AGIOS PHARMACEUTICALS, INC. (AGIO)

Sale of 500 shares at $37.52 per share.

Reporting Person Gheuens Sarah · Officer Title Chief Medical Officer · Transaction Code S

Traded Oct 22, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001439222-26-000122 · filed 2026-10-23 · View filing →

SEC FORM 4
$37,239.89

AGIOS PHARMACEUTICALS, INC. (AGIO)

Acquisition (code M) of 1,489 shares at $25.01 per share.

Reporting Person Gheuens Sarah · Officer Title Chief Medical Officer · Transaction Code M

Traded Oct 21, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001439222-26-000122 · filed 2026-10-23 · View filing →

SEC FORM 4
$55,882.17

AGIOS PHARMACEUTICALS, INC. (AGIO)

Sale of 1,489 shares at $37.53 per share.

Reporting Person Gheuens Sarah · Officer Title Chief Medical Officer · Transaction Code S

Traded Oct 21, 2026 · Disclosed Oct 23, 2026

Source: SEC Form 4 · 0001439222-26-000122 · filed 2026-10-23 · View filing →